[Elsevier] Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study

Ranaz Post time The day before yesterday 22:00 | Show all posts |Read mode
This post will be closed automatically in 2026-07-01 21:52
Reward10points


Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list